DHCR24 is a direct target of the stem cell regulator SOX9, and in a diffuse large B‐cell lymphoma (DLBCL) cell line xenograft model, knockdown of SOX9 resulted in reduced DHCR24 levels, decreased cholesterol content, and reduced tumor load. Here, SOX9 is linked to neoplasm.